First Time Loading...

Jilin Aodong Pharmaceutical Group Co Ltd
SZSE:000623

Watchlist Manager
Jilin Aodong Pharmaceutical Group Co Ltd Logo
Jilin Aodong Pharmaceutical Group Co Ltd
SZSE:000623
Watchlist
Price: 13.95 CNY -0.29% Market Closed
Updated: Jun 9, 2024

Income Statement

Earnings Waterfall
Jilin Aodong Pharmaceutical Group Co Ltd

Revenue
3.5B CNY
Cost of Revenue
-1.9B CNY
Gross Profit
1.6B CNY
Operating Expenses
-1.4B CNY
Operating Income
178.6m CNY
Other Expenses
939.2m CNY
Net Income
1.1B CNY

Income Statement
Jilin Aodong Pharmaceutical Group Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
2 091
N/A
2 227
+6%
2 272
+2%
2 240
-1%
2 241
+0%
2 245
+0%
2 241
0%
2 335
+4%
2 378
+2%
2 413
+1%
2 543
+5%
2 737
+8%
2 670
-2%
2 745
+3%
2 869
+5%
2 977
+4%
3 183
+7%
3 332
+5%
3 386
+2%
3 324
-2%
3 439
+3%
3 386
-2%
3 286
-3%
3 088
-6%
2 734
-11%
2 567
-6%
2 346
-9%
2 252
-4%
2 308
+2%
2 213
-4%
2 234
+1%
2 304
+3%
2 417
+5%
2 471
+2%
2 618
+6%
2 868
+10%
3 019
+5%
3 201
+6%
3 309
+3%
3 449
+4%
3 523
+2%
Gross Profit
Cost of Revenue
(694)
(715)
(722)
(695)
(760)
(803)
(749)
(726)
(742)
(712)
(771)
(830)
(841)
(882)
(938)
(890)
(968)
(998)
(1 003)
(945)
(1 025)
(1 032)
(1 017)
(971)
(965)
(933)
(931)
(929)
(1 018)
(1 044)
(1 092)
(1 111)
(1 199)
(1 280)
(1 335)
(1 417)
(1 560)
(1 599)
(1 662)
(1 768)
(1 913)
Gross Profit
1 398
N/A
1 511
+8%
1 550
+3%
1 546
0%
1 482
-4%
1 442
-3%
1 492
+3%
1 609
+8%
1 636
+2%
1 702
+4%
1 772
+4%
1 906
+8%
1 829
-4%
1 864
+2%
1 931
+4%
2 087
+8%
2 215
+6%
2 334
+5%
2 383
+2%
2 379
0%
2 413
+1%
2 354
-2%
2 269
-4%
2 117
-7%
1 769
-16%
1 634
-8%
1 415
-13%
1 323
-7%
1 289
-3%
1 169
-9%
1 142
-2%
1 192
+4%
1 217
+2%
1 191
-2%
1 283
+8%
1 451
+13%
1 459
+1%
1 602
+10%
1 647
+3%
1 681
+2%
1 609
-4%
Operating Income
Operating Expenses
(1 208)
(1 274)
(1 274)
(1 214)
(1 189)
(1 172)
(1 227)
(1 307)
(1 296)
(1 342)
(1 383)
(1 565)
(1 527)
(1 565)
(1 632)
(1 671)
(1 761)
(1 864)
(1 921)
(1 996)
(2 080)
(2 011)
(1 902)
(1 835)
(1 549)
(1 507)
(1 376)
(1 290)
(1 308)
(1 204)
(1 166)
(1 105)
(1 067)
(1 037)
(1 100)
(1 250)
(1 228)
(1 363)
(1 401)
(1 459)
(1 431)
Selling, General & Administrative
(1 150)
(1 223)
(1 220)
(1 187)
(1 185)
(1 158)
(1 217)
(1 279)
(1 294)
(1 341)
(1 381)
(1 533)
(1 487)
(1 538)
(1 611)
(1 753)
(1 875)
(1 982)
(2 024)
(1 981)
(2 074)
(1 973)
(1 883)
(1 770)
(1 490)
(1 472)
(1 341)
(1 271)
(1 297)
(1 188)
(1 154)
(1 092)
(1 097)
(1 069)
(1 110)
(1 195)
(1 206)
(1 342)
(1 376)
(1 379)
(1 372)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
0
(9)
0
(20)
(86)
(87)
(111)
(138)
(134)
(106)
(100)
(83)
(59)
(69)
(64)
(51)
(40)
(49)
(48)
(62)
(73)
(88)
(99)
(99)
(111)
(131)
Depreciation & Amortization
0
0
0
(26)
0
0
0
(28)
0
0
0
(32)
0
0
0
(31)
0
0
0
(37)
0
0
0
(44)
0
0
0
(62)
0
0
0
(58)
0
0
0
(60)
0
0
0
(60)
0
Other Operating Expenses
(59)
(51)
(53)
(0)
(5)
(13)
(10)
(0)
(2)
(1)
(2)
(0)
(39)
(28)
(19)
113
124
118
123
108
80
72
119
113
47
66
49
102
59
48
38
85
79
80
71
78
66
78
74
92
72
Operating Income
190
N/A
238
+25%
277
+16%
332
+20%
292
-12%
270
-8%
265
-2%
302
+14%
340
+13%
359
+6%
389
+8%
342
-12%
302
-12%
299
-1%
299
+0%
416
+39%
455
+9%
469
+3%
462
-2%
383
-17%
333
-13%
343
+3%
367
+7%
282
-23%
220
-22%
128
-42%
39
-69%
33
-15%
(19)
N/A
(36)
-92%
(24)
+32%
87
N/A
150
+73%
154
+2%
183
+19%
201
+10%
231
+15%
239
+3%
247
+3%
222
-10%
179
-20%
Pre-Tax Income
Interest Income Expense
973
1 013
1 092
1 114
1 486
2 257
2 235
2 254
1 992
1 385
1 455
1 298
1 390
1 428
1 427
1 506
1 370
1 142
968
575
985
893
895
1 252
892
1 466
1 752
1 713
1 800
1 680
1 979
1 671
1 237
1 067
233
921
1 403
1 539
1 755
1 126
738
Non-Reccuring Items
0
0
0
(26)
0
0
0
(1)
0
0
0
(10)
(1)
(1)
8
5
6
6
13
19
15
15
(1)
(58)
(0)
(0)
(0)
(26)
(1)
(1)
(1)
5
(1)
3
3
2
3
36
36
34
36
Gain/Loss on Disposition of Assets
(0)
0
(0)
17
(2)
(2)
(2)
(3)
(2)
(2)
(3)
(2)
0
0
0
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
Total Other Income
67
70
60
48
67
79
84
118
120
110
105
112
106
91
86
7
8
11
19
13
12
12
3
4
(5)
(6)
(6)
(3)
(3)
(1)
(2)
4
1
2
355
597
600
597
245
118
130
Pre-Tax Income
1 229
N/A
1 320
+7%
1 428
+8%
1 485
+4%
1 843
+24%
2 604
+41%
2 582
-1%
2 670
+3%
2 449
-8%
1 851
-24%
1 946
+5%
1 740
-11%
1 796
+3%
1 815
+1%
1 819
+0%
1 933
+6%
1 838
-5%
1 627
-11%
1 461
-10%
989
-32%
1 345
+36%
1 263
-6%
1 265
+0%
1 480
+17%
1 107
-25%
1 587
+43%
1 784
+12%
1 717
-4%
1 778
+4%
1 642
-8%
1 952
+19%
1 767
-10%
1 388
-21%
1 227
-12%
774
-37%
1 721
+122%
2 237
+30%
2 411
+8%
2 283
-5%
1 500
-34%
1 083
-28%
Net Income
Tax Provision
(129)
(141)
(148)
(68)
(69)
(68)
(61)
(69)
(71)
(73)
(82)
(84)
(87)
(89)
(87)
(88)
(86)
(85)
(86)
(64)
(101)
(76)
(76)
(86)
(30)
(47)
(50)
(25)
(25)
(10)
(71)
4
49
77
199
80
(1)
(47)
(99)
(56)
3
Income from Continuing Operations
1 100
1 179
1 280
1 418
1 775
2 536
2 521
2 602
2 378
1 779
1 864
1 656
1 709
1 727
1 732
1 845
1 752
1 542
1 375
925
1 244
1 187
1 189
1 393
1 077
1 539
1 734
1 691
1 753
1 632
1 881
1 771
1 437
1 304
973
1 801
2 236
2 365
2 184
1 444
1 087
Income to Minority Interest
(4)
(4)
(6)
(7)
(8)
(6)
(7)
(8)
(8)
(7)
(7)
11
12
13
23
18
18
19
15
11
11
12
10
10
11
12
14
18
19
19
17
10
11
9
(5)
(20)
(29)
(15)
(9)
16
31
Net Income (Common)
1 097
N/A
1 175
+7%
1 274
+8%
1 411
+11%
1 767
+25%
2 530
+43%
2 515
-1%
2 594
+3%
2 370
-9%
1 772
-25%
1 857
+5%
1 667
-10%
1 722
+3%
1 740
+1%
1 755
+1%
1 864
+6%
1 770
-5%
1 561
-12%
1 390
-11%
935
-33%
1 255
+34%
1 199
-4%
1 199
N/A
1 404
+17%
1 087
-23%
1 552
+43%
1 748
+13%
1 709
-2%
1 772
+4%
1 651
-7%
1 898
+15%
1 781
-6%
1 448
-19%
1 313
-9%
968
-26%
1 781
+84%
2 207
+24%
2 349
+6%
2 174
-7%
1 460
-33%
1 118
-23%
EPS (Diluted)
0.95
N/A
1.02
+7%
1.1
+8%
1.21
+10%
1.52
+26%
2.17
+43%
2.16
0%
2.23
+3%
2.03
-9%
1.52
-25%
1.6
+5%
1.43
-11%
1.49
+4%
1.5
+1%
1.5
N/A
1.6
+7%
1.51
-6%
1.33
-12%
1.19
-11%
0.8
-33%
1.07
+34%
1.03
-4%
1.03
N/A
1.21
+17%
0.94
-22%
1.33
+41%
1.45
+9%
1.43
-1%
1.52
+6%
1.46
-4%
1.66
+14%
1.51
-9%
1.24
-18%
1.16
-6%
0.77
-34%
1.36
+77%
1.81
+33%
2.08
+15%
1.92
-8%
1.12
-42%
0.99
-12%

See Also

Discover More